Clinical Trial

Trial Protocol ID USOR 21181_ZEN003694-201

Trial Description

Randomized Phase 2b Study of ZEN003694 in Combination with Enzalutamide versus Enzalutamide Monotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Mohit Narang, MD

Disease Types

Sponsors

  • Newsoara Biopharma (Shanghai) Co., Ltd.
  • Tigermed
  • Zenith Epigenetics Ltd.

ClinicalTrials.gov NCT ID

  • NCT04986423